Procter & Gamble Health Limited reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was INR 3,099.7 million compared to INR 3,099.7 million a year ago. Revenue was INR 3,151.5 million compared to INR 3,145.1 million a year ago. Net income was INR 720.7 million compared to INR 768 million a year ago. Basic earnings per share from continuing operations was INR 43.4 compared to INR 46.3 a year ago. Diluted earnings per share from continuing operations was INR 43.4 compared to INR 46.3 a year ago.
For the six months, sales was INR 6,149 million compared to INR 6,075.2 million a year ago. Revenue was INR 6,261.3 million compared to INR 6,154.8 million a year ago. Net income was INR 1,376.4 million compared to INR 1,404.6 million a year ago. Basic earnings per share from continuing operations was INR 82.9 compared to INR 84.6 a year ago. Diluted earnings per share from continuing operations was INR 82.9 compared to INR 84.6 a year ago.